Brune De Dreuille
Paris, 75018, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification of Pappalysin-2 (PAPP-A2), a modulator of Insulin-like Growth Factor-1 pathway, as a potential marker of teduglutide efficacy in patients with short bowel syndrome.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: December 05, 2024
Survival and parenteral nutrition dependence in patients aged 65 y and older with short bowel syndrome: a retrospective observational cohort study.
Journal: The American journal of clinical nutrition
Published: August 19, 2024
Emerging drugs for the treatment of short bowel syndrome.
Journal: Expert opinion on emerging drugs
Published: May 18, 2024
Hyperphagia is prominent in adult patients with short bowel syndrome: A role for the colon?
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: June 09, 2023
Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
Journal: Nutrients
Published: April 23, 2023
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
Journal: The American journal of clinical nutrition
Published: November 16, 2022
Disease-modifying therapies in short bowel syndrome.
Journal: Current opinion in pharmacology
Published: January 17, 2022
Short bowel syndrome: From intestinal insufficiency to intestinal adaptation
Journal: Medecine sciences : M/S
Published: September 07, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026